QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

Clinical trial NCT03132155 · TERMINATED

Trial details

NCT number: NCT03132155
Sponsor: NantPharma, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Sarcoma

Start date: 2018-08-29
Primary completion: 2021-08-13
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.